US EditionPublished • loading... • Updated
White House adds AbbVie's Humira to TrumpRx alongside cheaper biosimilars
Summary by endpoints.news
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
White House adds AbbVie's Humira to TrumpRx alongside cheaper biosimilars
The White House this week began offering a $950 per month version of AbbVie's megablockbuster Humira on TrumpRx, even as the drug discount website also offers two Humira biosimilars from Pfizer and Amgen that both cost less than $300 per month.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
